These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33336246)

  • 1. Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
    Bilgin ZD; Evcil I; Yazgi D; Binay G; Okuyucu Genc C; Gulsen B; Huseynova A; Ozdemir AZ; Ozmen E; Usta Y; Ustun S; Caglar Andac S
    J Chromatogr Sci; 2021 Aug; 59(8):748-757. PubMed ID: 33336246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
    Lammers AJJ; Brohet RM; Theunissen REP; Koster C; Rood R; Verhagen DWM; Brinkman K; Hassing RJ; Dofferhoff A; El Moussaoui R; Hermanides G; Ellerbroek J; Bokhizzou N; Visser H; van den Berge M; Bax H; Postma DF; Groeneveld PHP
    Int J Infect Dis; 2020 Dec; 101():283-289. PubMed ID: 33007454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
    Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
    Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
    Chen Y; Li MX; Lu GD; Shen HM; Zhou J
    Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
    Quiros Roldan E; Biasiotto G; Magro P; Zanella I
    Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
    Altulea D; Maassen S; Baranov MV; van den Bogaart G
    J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
    Das RR; Behera B; Mishra B; Naik SS
    Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
    Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
    Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
    Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
    J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
    Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P
    Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update.
    Joshi G; Thakur S; Mayank ; Poduri R
    Food Chem Toxicol; 2021 May; 151():112106. PubMed ID: 33722600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
    Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E
    Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical Methods on Determination in Pharmaceuticals and Biological Materials of Chloroquine as Available for the Treatment of COVID-19.
    Saka C
    Crit Rev Anal Chem; 2022; 52(1):19-34. PubMed ID: 32628049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.